Literature DB >> 6995541

Interrelation of the renin system and erythropoietin in rats.

A B Gould, S Goodman, R DeWolf, G Onesti, C Swartz.   

Abstract

Evidence is presented implicating the renin-angiotensin system in the regulation of plasma erythropoietin concentration. Male and female rats were exposed to hypoxia at 0.43 atm for 8 hr. In male rats, individual erythropoietin values showed a positive correlation with renin, renin substrate, and angiotensin I after 8 hr of hypoxia. In female rats, renin was not elevated during hypoxia. However, after renin was injected subcutaneously, plasma renin values became similar to those in male rats and erythropoietin doubled. Individual erythropoietin values of the combined groups showed a positive correlation with plasma renin. A single oral dose of SQ 14225, an angiotensin I-converting enzyme inhibitor, reduced erythropoietin to undetectable levels in renin-injected female rats. Angiotensin II, in subpressor amounts, prevented the suppression of erythropoietin by SQ 14225. SQ 14225 also reduced renin substrate concentration at ambient pressure and during hypoxic exposure. The correlation coefficient between renin substrate and erythropoietin in rats given SQ 14225 to lower substrate or angiotensin II to increase substrate was 0.85; p < 0.0005. The increase in renin substrate that occurred during hypoxia in female rats given angiotensin II correlated positively with erythropoietin, r = 0.86; p < 0.0005.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995541

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.

Authors:  M C Pratt; N J Lewis-Barned; R J Walker; R R Bailey; B I Shand; J Livesey
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

3.  Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.

Authors:  Prakash Vishnu; Yenny Moreno Vanegas; Hani M Wadei; Candido E Rivera
Journal:  BMJ Case Rep       Date:  2018-06-28

4.  Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.

Authors:  S M Freudenthaler; T Schenck; I Lucht; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

5.  Renal clearance of endogenous erythropoietin in patients with proteinuria.

Authors:  M Nowicki; F Kokot; M Kokot; A Bar; J Duława
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 6.  Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.

Authors:  A L Kamper
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

7.  Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

Authors:  S Freudenthaler; P Benöhr; A Grenz; T Selzer; T Schmidt; K Mörike; H Osswald; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

8.  Factors influencing plasma renin and renin substrate in premature infants.

Authors:  T J Stephenson; F Broughton Pipkin; A C Elias-Jones
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

9.  Deep learning-based predictive identification of neural stem cell differentiation.

Authors:  Yanjing Zhu; Ruiqi Huang; Zhourui Wu; Simin Song; Liming Cheng; Rongrong Zhu
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.